Article
Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
Human immunology - 1 Feb 2011
Kutikhin Anton G
Abstract excerpt
Toll-like receptor 4 (TLR4) is one of the key immune system effectors playing the main role in recognition of viruses and bacteria. Dysregulation of the TLR4 signaling owing to single nucleotide polymorphisms (SNPs) may alter the ligand binding and balance between pro- and anti-inflammatory cytokines, thereby modulating the risk of chronic inflammation and cancer. TLR4 polymorphisms may be associated with at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
